Agglomeration inhibition reflected stone-forming activity during long–term potassium citrate therapy in calcium stone formers
- 1 December 1998
- Vol. 52 (6) , 988-994
- https://doi.org/10.1016/s0090-4295(98)00361-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Urinary tamm-horsfall protein increased after potassium citrate therapy in calcium stone formersUrology, 1995
- Calcium Oxalate Stone Agglomeration Reflects Stone-Forming Activity: Citrate Inhibition Depends on Macromolecules Larger Than 30 KilodaltonAmerican Journal of Kidney Diseases, 1994
- Calcium oxalate nephrolithiasis, a free or fixed particle diseaseKidney International, 1994
- Randomized Double-Blind Study of Potassium Citrate in Idiopathic Hypocitraturic Calcium NephrolithiasisJournal of Urology, 1993
- Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregationAmerican Journal of Physiology-Renal Physiology, 1993
- Can citrate therapy prevent nephrolithiasis?Urology, 1993
- The Effects of a Single Evening Dose of Alkaline Citrate on Urine Composition and Calcium Stone FormationJournal of Urology, 1992
- Citrate and recurrent idiopathic calcium urolithiasisUrological Research, 1992
- Crystal agglomeration is a major element in calcium oxalate urinary stone formationKidney International, 1990
- Hypercalciuria and Hyperuricosuria in Patients with Calcium NephrolithiasisNew England Journal of Medicine, 1974